Expanding indications for ESD: submucosal disease (SMT/carcinoid tumors)

Osamu Goto1, Toshio Uraoka1, Joichiro Horii1

  • 1Division of Research and Development for Minimally Invasive Treatment, Cancer Center, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.